Carboxyl-terminal_JJ
15-amino_JJ
acid_NN
sequence_NN
of_IN
NFATx1_NN
is_VBZ
possibly_RB
created_VBN
by_IN
tissue-specific_JJ
splicing_NN
and_CC
is_VBZ
essential_JJ
for_IN
transactivation_NN
activity_NN
in_IN
T_NN
cells_NNS
._.

NFAT_NN
regulates_VBZ
transcription_NN
of_IN
a_DT
number_NN
of_IN
cytokine_NN
and_CC
other_JJ
immunoregulatory_JJ
genes_NNS
._.

We_PRP
have_VBP
isolated_VBN
NFATx_NN
,_,
which_WDT
is_VBZ
one_CD
of_IN
four_CD
members_NNS
of_IN
the_DT
NFAT_NN
family_NN
of_IN
transcription_NN
factors_NNS
and_CC
is_VBZ
preferentially_RB
expressed_VBN
in_IN
the_DT
thymus_NN
and_CC
peripheral_JJ
blood_NN
leukocytes_NNS
,_,
and_CC
an_DT
isoform_NN
of_IN
NFATx_NN
,_,
NFATx1_NN
._.

Here_RB
we_PRP
provide_VBP
evidence_NN
showing_VBG
that_IN
15_CD
amino_NN
acids_NNS
in_IN
the_DT
carboxyl-terminal_JJ
end_NN
of_IN
NFATx1_NN
are_VBP
required_VBN
for_IN
its_PRP$
maximum_JJ
transactivation_NN
activity_NN
in_IN
Jurkat_NN
T_NN
cells_NNS
._.

A_DT
fusion_NN
between_IN
these_DT
15_CD
amino_NN
acids_NNS
and_CC
the_DT
GAL4_NN
DNA_NN
binding_NN
domain_NN
was_VBD
capable_JJ
of_IN
transactivating_VBG
reporters_NNS
driven_VBN
by_IN
the_DT
GAL4_NN
DNA_NN
binding_NN
site_NN
._.

Interestingly_RB
,_,
this_DT
15-amino_JJ
acid_NN
transactivation_NN
sequence_NN
is_VBZ
well_RB
conserved_VBN
in_IN
NFAT_NN
family_NN
proteins_NNS
,_,
although_IN
the_DT
sequences_NNS
contiguous_JJ
to_TO
the_DT
carboxyl-terminal_JJ
regions_NNS
of_IN
the_DT
NFAT_NN
family_NN
are_VBP
much_RB
less_RBR
conserved_VBN
._.

We_PRP
also_RB
report_VBP
three_CD
additional_JJ
isoforms_NNS
of_IN
NFATx_NN
,_,
designated_VBN
NFATx2_NN
,_,
NFATx3_NN
,_,
and_CC
NFATx4_NN
._.

This_DT
transactivation_NN
sequence_NN
is_VBZ
altered_VBN
by_IN
tissue-specific_JJ
alternative_JJ
splicing_NN
in_IN
newly_RB
isolated_VBN
NFATx_NN
isoforms_NNS
,_,
resulting_VBG
in_IN
lower_JJR
transactivation_NN
activity_NN
in_IN
Jurkat_NN
T_NN
cells_NNS
._.

NFATx1_NN
is_VBZ
expressed_VBN
predominantly_RB
in_IN
the_DT
thymus_NN
and_CC
peripheral_JJ
blood_NN
leukocyte_NN
,_,
while_IN
the_DT
skeletal_JJ
muscle_NN
expressed_VBD
primarily_RB
NFATx2_NN
._.

In_IN
Jurkat_NN
cells_NNS
,_,
transcription_NN
from_IN
the_DT
NFAT_NN
site_NN
of_IN
the_DT
IL-2_NN
promoter_NN
is_VBZ
activated_VBN
strongly_RB
by_IN
NFATx1_NN
but_CC
only_RB
weakly_RB
by_IN
NFATx2_NN
._.

These_DT
data_NNS
demonstrate_VBP
that_IN
the_DT
15-amino_JJ
acid_NN
sequence_NN
of_IN
NFATx1_NN
is_VBZ
a_DT
major_JJ
transactivation_NN
sequence_NN
required_VBN
for_IN
induction_NN
of_IN
genes_NNS
by_IN
NFATx1_NN
in_IN
T_NN
cells_NNS
and_CC
possibly_RB
regulates_VBZ
NFAT_NN
activity_NN
through_IN
tissue-specific_JJ
alternative_JJ
splicing_NN
._.

